Click here to view the printer friendly version of this press release
ALBUQUERQUE, N.M.-- The National Foundation for Cancer Research (NFCR) has listed the SQUID-based cancer imaging technology developed by MHTX's (OTCBB: MHTX) Senior Scientific subsidiary as a "2012 Research Breakthrough." http://nfcr.org/research/research-accomplishments The t.echnology was developed by Edward R. Flynn, PhD, Senior Scientific’s founder and chief scientist, in collaboration with Richard S. Larson, MD, PhD, Executive Vice Chancellor UNM Health Sciences Center in New Mexico.
The NFCR has supported Dr. Robert C. Bast, Jr. of The University of Texas MD Anderson Cancer Center to collaborate with Senior Scientific in applying Senior Scientific’s technology to the early detection of ovarian cancer. The collaboration was previously press released at http://www.mhtx.com/press-releases/national-foundation-funds-novel-approach-to-early-cancer-detection/ Dr. B.ast is a world leader in the early detection of ovarian cancer. He was responsible for the discovery of the most accurate marker for this disease, CA-125. Dr. Bast and Senior Scientific are working to apply the SQUID-based imaging technology to help save many women's lives from ovarian cancer - the notorious "silent killer" which often escapes early detection and becomes too difficult to treat when eventually diagnosed.
The technology uses Superconducting Quantum Interference Devices (SQUIDs) and non-toxic iron oxide nanoparticles to find and measure cancer and to develop new biomarkers for targeting specific cancers. It is expected to be able to detect cancer years earlier than existing techniques as well as find cancers not detectable by current methods through these new biomarkers. The technology is applicable to many cancers and has been demonstrated in application to ovarian cancer, breast cancer, prostate cancer and leukemia.